Dr. Glenn Weston is a counsel in Dechert’s global finance team in London. Dr. Weston's main area of practice is within the field of securitization, with a particular focus on CLOs.
Dr. Weston has worked on both the buy- and sell-side of transactions, acting for numerous CLO managers, bank arrangers, and third-party equity financial providers in connection with a variety of European CLO transactions (including resets, refinancings and reissuances) and associated loan warehouse facilities.
Dr. Weston regularly advises on structuring US and European CLOs to comply with various European regulatory requirements, including those imposed by the EU and UK securitization regulations.
Before joining Dechert, Dr. Weston trained and worked at two leading U.S. law firms and was seconded for nine months to a leading European investment bank where he acted as the sole in-house counsel for their European CLO trading desk.
Dr. Weston is recommended by The Legal 500 UK 2024 for securitization.
-
- Durham University, B.Sc., Cellular Biology, 2002, First Class (Hons), Cellular Biology Prize (awarded for coming first in the year in the field of Cellular Biology), John Norton Prize (award for coming first in the year in the field of Biological Sciences)
- University of Cambridge, Ph.D., Immunology, 2007, Received BBSRC CASE scholarship (with industry placement)
- BPP University, GDL, 2009, Commendation
- BPP University, LPC, 2010, Distinction
-
- England and Wales